Loading...
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks
Objective: To evaluate the continued safety and durability of clinical response in patients with ankylosing spondylitis receiving etanercept. Methods: 277 patients who had participated in a previous randomised, double blind, placebo controlled 24 week trial were eligible to continue in this open lab...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2005
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1755272/ https://ncbi.nlm.nih.gov/pubmed/15843448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2004.035105 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|